Injectable contraceptives are among the most popular family planning options. They are safe, effective, and discreet, but in many countries women in rural and remote communities often travel long distances to reach clinics that offer injectable contraceptives.
At the request of the Malawi Ministry of Health and USAID/Malawi, FHI 360, through the U.S. Agency for International Development’s Advancing Partners & Communities project, conducted a randomized controlled trial comparing continuation rates of women who self-injected DMPASC and women who received DMPA-SC from a provider, including CHWs.
